The one-year forecast is especially strong, with a signal strength of 42.17 and a predictability of 0.49. This makes sense considering the strong fundamental analysis of the company. The continued success of the HVC drugs Solvadi and Harvoni and the possibility of a deal to enter into the HBC market make the stock bullish during the rest of the year.
Forecast Length: 1 Month (4/30/15 – 5/30/15)
Disclaimer:
I Know First-Daily Market Forecast, does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, stock forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.